Xconomy Boston

Helix Therapeutics Obtains $965,000 New Round

  • Feed Type
  • Date
    3/5/2009
  • Company Name
    Helix Therapeutics
  • Mailing Address
    Undisclosed New Haven, CT 06520
  • Company Description
    The company is developing DNA therapeutics that will cause a paradigm shift in the way that common genetic diseases are treated…by permanently curing them.
  • Website
    http://www.helixtherapeutics.com
  • Transaction Type
    Venture Equity
  • Transaction Amount
    $965,000
  • Transaction Round
    Undisclosed
  • Proceeds Purposes
    Proceeds purposes were not disclosed.
  • M&A Terms
  • Venture Investor
    Connecticut Innovations
  • Venture Investor
    Launch Capital
  • Venture Investor
    Undisclosed

Add Your Thoughts

You will have 10 minutes to edit your post after you press publish.

Comments may be edited for clarity and length, rejected, or deleted.
By clicking "Publish," you are agreeing to these Terms and Conditions.

    

Business, life sciences, and technology news — covering Boston, Seattle, San Diego, Detroit, San Francisco, New York and beyond.

© 2007-2012, Xconomy, Inc. Xconomy is a registered service mark of Xconomy, Inc. All rights reserved.

Site produced by Andrew Koyfman with design from Rob Hunter.